Shares Basic Information

Basic Information

Code Number 7459
Stock Listing Tokyo Stock Exchange, First Section
Fiscal Year From April 1 to March 31 of Followin Year
The Ordinary General Meeting of Shareholders June
Record Date Fiscal Year-End: March 31  Interim: September 30

Dividend payments, in accordance with the Articles of Incorporation, are made after a full three years.

Trading Unit 100 shares
Method of Public Notice Announcements are made in the Nihon Keizai Shimbun.
Number of Shares Authorized 900,000,000 (As of March 31, 2018)
Number of Outstanding Shares 244,524,496 (As of March 31, 2018)
Shareholders 11,264 (As of March 31, 2018)

Major Shareholders

(As of March 31, 2018)

Shareholder Number of Shares Owned
(thousands of shares)
Ratio of Shares Owned
Takeda Pharmaceutical Company Limited 22,900 10.18
Japan Trustee Services Bank, Ltd. (Trust Account) 7,811 3.47
MEDICEO Employees Shareholders’ Association of MP Group 7,577 3.37
The Master Trust Bank of Japan, Ltd. (Trust Account) 7,168 3.19
Japan Trustee Services Bank, Ltd.
(Eisai Co., Ltd. Retirement Benefit Trust Account re-entrusted by Sumitomo Mitsui Trust Bank, Limited.)
5,845 2.60
Kobayashi Pharmaceutical Co., Ltd. 5,074 2.26
Northern Trust Co. (Avfc) Re The Kiltearn Global Equity Fund 4,560 2.03
Japan Trustee Services Bank, Ltd. (Trust Account 5) 3,771 1.68
State Street Bank West Client - Treaty 505234 3,296 1.47
Trust & Custody Services Bank, Ltd. as trustee for Daiichi Sankyo Company, Limited Retirement Benefit Trust Account re-entrusted by Mizuho Trust & Banking Co., Ltd. 3,274 1.46


  1. The Company holds 19,613 thousand shares of treasury stock, but is not included in the above list of major shareholders.
  2. Holding ratios are calculated from the total number of issued shares, less treasury stock.
  3. Holding ratios are rounded to the third decimal place.

Adobe Reader is required in order to view the PDF files.
If you do not have Adobe Reader installed, please download it from the left icon.